NCT03147066

Dezocine for Prevention of Catheter-related Bladder Discomfort

Efficacy of Dezocine for the Prevention of Catheter-related Bladder Discomfort

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 96 (actual)
• Sponsor: Jian-jun Yang · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates the efficacy of dezocine in preventing the catheter-related bladder discomfort (CRBD) in a postanesthesia care unit (PACU).

Detailed description

Thirty min before the end of the surgery, patients were randomly assigned to one of the two group to receive intravenous dezocine 0.1 mg/kg (Group D, n=48) or flurbiprofen axetil 1 mg/kg (Group F, n=48) . The CRBD was assessed at 0, 1, 2, and 6 h after patient's arrival in the post-anaesthesia care unit. Severity of CRBD was graded as none, mild, moderate and severe.

Conditions

• Catheter Related Bladder Discomfort

Interventions

Type	Name	Description
DRUG	Dezocine	Dezocine (0.1 mg/kg）will be infused during surgery
DRUG	Flurbiprofen Axetil	Flurbiprofen Axetil (1 mg/kg）will be infused during surgery

Timeline

• Start date: 2017-09-01
• Primary completion: 2017-10-30
• Completion: 2017-10-30
• First posted: 2017-05-10
• Last updated: 2017-10-31

Locations

1 site across 1 country: China